Search Results - "Ehrlich, Hartmut"
-
1
The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages
Published in Scientific reports (07-07-2017)“…The progression of human immunodeficiency virus (HIV) is associated with mucosal damage in the gastrointestinal (GI) tract. This damage enables bacterial…”
Get full text
Journal Article -
2
Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models
Published in Molecular cancer therapeutics (02-12-2022)“…Immune checkpoint blockers (ICB) provide a promising approach to antitumor immunotherapy through blockade of immunosuppressive pathways. The synthetic…”
Get full text
Journal Article -
3
-
4
Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing
Published in Scientific reports (28-01-2019)“…ABX464 is a first-in-class, clinical-stage, small molecule for oral administration that has shown strong anti-inflammatory effects in the DSS-model for…”
Get full text
Journal Article -
5
-
6
S1097 Correlation of miR-124 Upregulation and PK Parameters in Blood of Patients With Moderate-to-Severe Ulcerative Colitis Receiving Obefazimod for 16 Weeks
Published in The American journal of gastroenterology (01-10-2023)“…The correlation between miR-124 upregulation and Cmax and AUC was tested with Spearman's non-parametric correlation analysis. The lack of significant PKPD…”
Get full text
Journal Article -
7
close look at human IgG sialylation and subclass distribution after lectin fractionation
Published in Proteomics (Weinheim) (01-09-2009)“…Polyspecific human IgG preparations are indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. In…”
Get full text
Journal Article -
8
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial
Published in The Lancet (British edition) (2011)“…Summary Background The use of cell-culture technologies for the manufacture of influenza vaccines might contribute to improved strain selection and robust…”
Get full text
Journal Article -
9
A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
Published in The New England journal of medicine (12-06-2008)“…There is a need for a vaccine against avian influenza (H5N1). In this initial study, the administration of two doses of a whole-virus H5N1 vaccine derived from…”
Get full text
Journal Article -
10
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial
Published in The Lancet infectious diseases (01-08-2013)“…Summary Background Lyme borreliosis is caused by Borrelia burgdorferi sensu stricto in the USA and by several Borrelia species in Europe and Asia, but no human…”
Get full text
Journal Article -
11
ABX464 (obefazimod) for patients with COVID-19 at risk for severe disease: miR-AGE, a randomized, double-blind placebo-controlled trial
Published in The journal of allergy and clinical immunology. Global (01-11-2023)“…BackgroundABX464 (obefazimod) is a small molecule that upregulates a single microRNA (miR-124) in immune cells and reduces the production of various…”
Get full text
Journal Article -
12
A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans
Published in The Journal of infectious diseases (01-06-2011)“…After vaccination of humans with tick-borne encephalitis virus (TBEV) vaccine, the extent of crossneutralization between viruses of the European, Far Eastern,…”
Get full text
Journal Article -
13
Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo
Published in Molecular cancer therapeutics (01-07-2013)“…Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine, originally discovered for its eponymous effect and now known for pleiotropic…”
Get full text
Journal Article -
14
Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity
Published in PloS one (24-01-2011)“…New highly pathogenic H5N1 influenza viruses are continuing to evolve with a potential threat for an influenza pandemic. So far, the H5N1 influenza viruses…”
Get full text
Journal Article -
15
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects
Published in Journal of antimicrobial chemotherapy (01-03-2017)“…An anti-HIV compound (ABX464) has been developed with a novel mechanism of activity in that it blocks viral gene expression in cells that are already infected…”
Get full text
Journal Article -
16
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models
Published in PloS one (23-02-2010)“…The recent emergence and rapid spread of a novel swine-derived H1N1 influenza virus has resulted in the first influenza pandemic of this century. Monovalent…”
Get full text
Journal Article -
17
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects
Published in Antimicrobial agents and chemotherapy (01-01-2017)“…ABX464 is an antiviral that provides a novel approach to the reduction and control of HIV infection. Investigation of food influence is important in the…”
Get full text
Journal Article -
18
The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants
Published in Vaccine (10-03-2009)“…Abstract Continuing additions of new vaccines to routine infant vaccination schedules have prompted concerns about potential interactions between vaccine…”
Get full text
Journal Article -
19
Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development
Published in Expert review of vaccines (01-04-2013)“…Several subtypes of influenza A viruses with pandemic potential are endemic in bird populations throughout Asia, Africa and the Middle East, and evidence…”
Get more information
Journal Article -
20
A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
Published in The Journal of infectious diseases (01-01-2012)“…A Vero cell-derived whole-virus H5N1 influenza vaccine has been shown to induce neutralizing antibodies directed against the hemagglutinin (HA) protein of…”
Get full text
Journal Article